Loading...
XNYSCTApA
Market cap11kUSD
Dec 23, Last price  
56.10USD
1D
0.14%
1Q
-12.33%
Jan 2017
-35.89%
Name

EIDP Inc

Chart & Performance

D1W1MN
XNYS:CTApA chart

Profile

E. I. du Pont de Nemours and Company provides seeds and crop protection products for the agriculture industry in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce yield for farms; offers corn, soybean, and other oil seeds; trait technologies that enhance resistance to weather, disease, insects, and herbicides, which is used to control weeds. It also enhances food and nutritional characteristics; and digital solutions that assist farmer decision-making with a view to optimizing product selection and yield. The Crop Protection segment serves the agricultural input industry with products that protect against weeds, insects and other pests, and diseases, as well as enhance overall crop health above and below ground via nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers and pasture, and range management herbicides. In addition, it offers its products under the Pioneer, Brevant, Dairyland Seed, Hoegemeyer, Nutech, Seed Consultants, AgVenture, Alforex, PhytoGen, Pannar, VP Maxx, HPT, G2, Supreme EX, XL, Power Plus, ENLIST E3, ENLIST, EXZACT, HERCULEX, Leptra, POWERCORE, Optimum, AcreMax, REFUGE ADVANCED, SMARTSTAX, NEXERA, Omega-9 Oils, AQUAmax, Plenish, ExpressSun, Protector, Pioneer MAXIMUS, Qrome, Clearfield, PROPOUND, Conkesta, Conkesta E3, WideStrike, LumiGEN, LUMIDERM, LUMIVIA, LUMIALZA, GRANULAR, ACREVALUE, Granular, and Insights brand names. The company was founded in 1802 and is headquartered in Wilmington, Delaware. E. I. du Pont de Nemours and Company is a subsidiary of Corteva, Inc.
URL
https://www.dupont.com/
IPO date
Mar 21, 1980
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
17,226,000
-1.31%
17,455,000
11.50%
15,655,000
10.11%
Cost of revenue
11,257,000
14,825,000
10,407,000
Unusual Expense (Income)
NOPBT
5,969,000
2,630,000
5,248,000
NOPBT Margin
34.65%
15.07%
33.52%
Operating Taxes
152,000
210,000
524,000
Tax Rate
2.55%
7.98%
9.98%
NOPAT
5,817,000
2,420,000
4,724,000
Net income
735,000
-35.92%
1,147,000
-34.79%
1,759,000
158.30%
Dividends
(439,000)
(418,000)
(397,000)
Dividend yield
Proceeds from repurchase of equity
(756,000)
(912,000)
(418,000)
BB yield
Debt
Debt current
198,000
24,000
17,000
Long-term debt
2,292,000
1,285,000
1,103,000
Deferred revenue
1,119,000
3,124,000
Other long-term liabilities
4,118,000
2,812,000
1,719,000
Net debt
(367,000)
(2,108,000)
(3,501,000)
Cash flow
Cash from operating activities
1,769,000
872,000
2,727,000
CAPEX
(595,000)
(605,000)
(573,000)
Cash from investing activities
(1,987,000)
(632,000)
(362,000)
Cash from financing activities
(99,000)
(1,180,000)
(1,266,000)
FCF
5,063,000
1,195,000
5,759,000
Balance
Cash
2,742,000
3,315,000
4,545,000
Long term investments
115,000
102,000
76,000
Excess cash
1,995,700
2,544,250
3,838,250
Stockholders' equity
(2,469,000)
(2,071,000)
(1,889,000)
Invested Capital
34,355,000
32,667,000
33,326,000
ROIC
17.36%
7.33%
13.77%
ROCE
18.21%
8.29%
16.07%
EV
Common stock shares outstanding
867,806
867,806
Price
Market cap
EV
EBITDA
7,180,000
3,853,000
6,491,000
EV/EBITDA
Interest
233,000
79,000
30,000
Interest/NOPBT
3.90%
3.00%
0.57%